Get started
Author

András Komócsi

Observed names: A KOMOCSI, A Komocsi, A Komócsi, A. Komocsi, A. Komócsi, Andras Komocsi, Komócsi, András
Institution: University of Pecs
ORCID: 0000-0002-8170-1778
Observed ORCID: 0000-0002-8170-1778
OpenAlex ID: A5073075473
Guided de-escalation of antiplatelet treatment in patients with acute coronary syndrome undergoing percutaneous coronary intervention (TROPICAL-ACS): a randomised, open-label, multicentre trial
2017 · Dirk Sibbing, Dániel Aradi, et al. · The Lancet · 633
PDF
Expert position paper on the role of platelet function testing in patients undergoing percutaneous coronary intervention
2013 · Dániel Aradi, Robert F. Storey, et al. · European Heart Journal · 280
PDF
Prevalence and factors associated with left ventricular dysfunction in the EULAR Scleroderma Trial and Research group (EUSTAR) database of patients with systemic sclerosis
2009 · Y Allanore, C Meune, et al. · Annals of the Rheumatic Diseases · 274
PDF
Prognostic significance of high on-clopidogrel platelet reactivity after percutaneous coronary intervention: Systematic review and meta-analysis
2010 · Dániel Aradi, András Komócsi, et al. · American Heart Journal · 211
Transradial versus transfemoral percutaneous coronary intervention in acute myocardial infarction
2009 · András Vorobcsuk, Attila Kónyi, et al. · American Heart Journal · 154
The impact of cardiopulmonary manifestations on the mortality of SSc: a systematic review and meta-analysis of observational studies
2012 · András Komócsi, András Vorobcsuk, et al. · Rheumatology · 143
Efficacy and safety of intensified antiplatelet therapy on the basis of platelet reactivity testing in patients after percutaneous coronary intervention: Systematic review and meta-analysis
2012 · Dániel Aradi, András Komócsi, et al. · International Journal of Cardiology · 142
Subcutaneous Versus Transvenous Implantable Defibrillator Therapy
2017 · Indranill Basu-Ray, Jing Liu, et al. · JACC. Clinical electrophysiology · 116
PDF
Optimizing P2Y12 Receptor Inhibition in Patients With Acute Coronary Syndrome on the Basis of Platelet Function Testing
2014 · Dániel Aradi, Adrienn Tornyos, et al. · Journal of the American College of Cardiology · 92
Use of New-Generation Oral Anticoagulant Agents in Patients Receiving Antiplatelet Therapy After an Acute Coronary Syndrome: Systematic Review and Meta-analysis of Randomized Controlled Trials
2012 · András Komócsi, András Vorobcsuk, et al. · Archives of Internal Medicine · 79
Ultrasound guidance for femoral venous access in electrophysiology procedures—systematic review and meta-analysis
2019 · Péter Kupó, Róbert Pap, et al. · Journal of Interventional Cardiac Electrophysiology · 70
PDF
Five-year follow-up of left ventricular diastolic function in systemic sclerosis patients: Determinants of mortality and disease progression
2014 · Réka Faludi, Gyöngyvér Költő, et al. · Seminars in Arthritis and Rheumatism · 56
Platelet reactivity and clinical outcomes in acute coronary syndrome patients treated with prasugrel and clopidogrel: a pre-specified exploratory analysis from the TROPICAL-ACS trial
2019 · Dániel Aradi, Lisa Gross, et al. · European Heart Journal · 55
Zero fluoroscopy catheter ablation for atrial fibrillation: a systematic review and meta-analysis
2023 · Dorottya Debreceni, Kristof Janosi, et al. · Frontiers in Cardiovascular Medicine · 53
PDF
Impact of Genetic Variants on Post-Clopidogrel Platelet Reactivity in Patients After Elective Percutaneous Coronary Intervention
2011 · Orsolya Rideg, András Komócsi, et al. · Pharmacogenomics · 53
A randomised trial on platelet function-guided de-escalation of antiplatelet treatment in ACS patients undergoing PCI: Rationale and design of the Testing Responsiveness to Platelet Inhibition on Chronic Antiplatelet Treatment for Acute Coronary Syndromes (TROPICAL-ACS) Trial
2016 · Claudius Jacobshagen, Lisa Gross, et al. · Thrombosis and Haemostasis · 49
PDF
Impact of clopidogrel and potent P2Y12-inhibitors on mortality and stroke in patients with acute coronary syndrome or undergoing percutaneous coronary intervention: A systematic review and meta-analysis
2012 · András Komócsi, András Vorobcsuk, et al. · Thrombosis and Haemostasis · 48
Age and outcomes following guided de-escalation of antiplatelet treatment in acute coronary syndrome patients undergoing percutaneous coronary intervention: results from the randomized TROPICAL-ACS trial
2018 · Dirk Sibbing, Lisa Gross, et al. · European Heart Journal · 47
Novel Mechanisms of Sildenafil in Pulmonary Hypertension Involving Cytokines/Chemokines, MAP Kinases and Akt
2014 · Tamas Kiss, Krisztina Kovacs, et al. · PLoS ONE · 47
PDF
Meta-Analysis Comparing Carvedilol Versus Metoprolol for the Prevention of Postoperative Atrial Fibrillation Following Coronary Artery Bypass Grafting
2013 · James J. DiNicolantonio, Craig J. Beavers, et al. · The American Journal of Cardiology · 41
Justification of 150 mg clopidogrel in patients with high on‐clopidogrel platelet reactivity
2011 · Dániel Aradi, Orsolya Rideg, et al. · European Journal of Clinical Investigation · 41
Early morphologic and functional changes of atherosclerosis in systemic sclerosis—a systematic review and meta-analysis
2016 · Zsófia Meiszterics, Orsolya Tímár, et al. · Rheumatology · 39
Zero and Minimal Fluoroscopic Approaches During Ablation of Supraventricular Tachycardias: A Systematic Review and Meta-Analysis
2022 · Dorottya Debreceni, Kristof Janosi, et al. · Frontiers in Cardiovascular Medicine · 37
Galectin-3 is an independent predictor of survival in systemic sclerosis
2016 · Réka Faludi, Gabriella Nagy, et al. · International Journal of Cardiology · 36
Overlap of coronary disease and pulmonary arterial hypertension in systemic sclerosis
2009 · A Komócsi, T Pintér, et al. · Annals of the Rheumatic Diseases · 36
Works count: 151
Citation count: 4,412
H-index: 31
I10-index: 68
Year
Topic
Type